Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
Oogenesis02:07

Oogenesis

68.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.9K
Ovaries01:26

Ovaries

2.1K
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
2.1K
Ovarian Cycle01:27

Ovarian Cycle

3.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.3K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

6.4K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva vs Plasma in Liquid Biopsy Sampling for Head and Neck Cancer: A Comparative Study.

Clinical chemistry·2026
Same author

Gynecologic Cancers: Cervical Cancer.

FP essentials·2025
Same author

Gynecologic Cancers: Endometrial Cancer.

FP essentials·2025
Same author

Gynecologic Cancers: Vulvar Cancer.

FP essentials·2025
Same author

Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Bridging the gap: associations of provider enrollment in OKCAPMAP with social deprivation, child abuse, and barriers to access in the state of Oklahoma, USA.

Journal of osteopathic medicine·2025

Related Experiment Video

Updated: Jan 11, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.4K

Gynecologic Cancers: Ovarian Cancer.

Bindusri Paruchuri1, Amanda Miller1

  • 1Department of Family Medicine at the University of Tennessee Health Science Center, College of Medicine- Nashville, TN.

FP Essentials
|November 18, 2025
PubMed
Summary
This summary is machine-generated.

Ovarian cancer is a lethal gynecologic malignancy with poor survival rates due to late diagnosis. Early recognition and referral are crucial for improved patient outcomes.

More Related Videos

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.1K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.9K

Related Experiment Videos

Last Updated: Jan 11, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.4K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.1K
Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

11.9K

Area of Science:

  • Gynecologic Oncology
  • Medical Diagnostics
  • Cancer Genetics

Background:

  • Ovarian cancer is the most lethal gynecologic malignancy in the US, with a 5-year survival rate of 50.9%.
  • Late diagnosis is common due to a lack of effective screening and vague symptoms, often after metastasis.
  • Genetic variants like BRCA1 and BRCA2 are significant risk factors, implicated in 10-15% of cases.

Purpose of the Study:

  • To highlight the challenges in ovarian cancer management, including screening and early detection.
  • To outline the recommended diagnostic workup and referral criteria for suspected ovarian cancer.
  • To emphasize the role of family physicians in patient support and disease recognition.

Main Methods:

  • Review of clinical presentation, risk factors, and diagnostic modalities for ovarian cancer.
  • Description of initial workup including pelvic/abdominal examination, transvaginal ultrasonography, and cancer antigen 125 levels.
  • Guidelines for referral to gynecologic oncology based on clinical and imaging findings.

Main Results:

  • Most ovarian cancers are diagnosed at advanced stages due to diagnostic challenges.
  • Genetic factors (BRCA1/2) play a key role in a subset of patients.
  • Improved survival rates are attributed to better management and treatment, not early detection advances.

Conclusions:

  • Ovarian cancer remains a significant health threat requiring prompt physician consideration for at-risk patients.
  • Timely referral to gynecologic oncology is essential for patients with concerning findings.
  • Family physicians are vital in long-term patient care, potentially improving early recognition and treatment support.